30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Mazor Robotics Posts 3Q16 Revenue -

Mazor Robotics reported 3Q16 revenue of US $7.6MM, +52.0% from 3Q15. (U.S. $5.7MM, +32.6%; ex-U.S. $1.9MM, +171.4%) Growth is as reported.

Sold 25 systems in 3Q, including:

  • 3 U.S. Mazor X pre-launch orders
  • 4 U.S. Renaissance orders
  • 3 ex-U.S. Renaissance orders (Australia, Germany, Thailand)
  • 15 Mazor X systems ordered by Medtronic


  • Officially launched Mazor X and received orders for 6 systems in first five weeks of 4Q (5 Mazor X, one Renaissance)
  • To date, 131 Renaissance systems installed globally, +36% year over year, with 79 in the U.S., +41%
  • <100 U.S. hospitals use Mazor systems presently (have penetrated <5% of the addressable market)
  • Completed second equity investment tranche of $20MM from Medtronic; commenced co-promotion and co-marketing efforts
  • >100 Medtronic sales reps trained on Mazor X

Sources: Mazor Robotics Inc.; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.